Median Technologies Reveals Voting Rights and Share Capital Structure

On December 3, 2025, Median Technologies, a company known for its expertise in medical device software and imaging services, released information on its share capital and voting rights as of November 30, 2025. The disclosure aligns with French regulatory requirements, particularly article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.

The total number of shares stands at 36,741,587. The number of real voting rights, excluding treasury shares, is 36,669,667. Including treasury shares, the theoretical number of voting rights is 36,718,387. Notably, Class E preference shares do not carry voting rights.

This structured disclosure underlines Median Technologies' compliance with financial regulations and offers transparency to investors and stakeholders about its corporate governance framework.